The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates

被引:100
|
作者
Chen, Kuangqi [1 ]
Li, Yanqing [1 ]
Zhang, Xuhong [1 ]
Ullah, Rahim [2 ]
Tong, Jianping [1 ]
Shen, Ye [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Ophthalmol, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Endocrinol,Natl Clin Res Ctr Child Hlth, Hangzhou 310052, Zhejiang, Peoples R China
关键词
GROWTH-FACTOR RECEPTOR; OXYGEN SPECIES ROS; SUBSTANCE-P; DRY EYE; INFLAMMASOME ACTIVATION; EGFR TRANSACTIVATION; HYDROGEN-PEROXIDE; CELL-MIGRATION; MOUSE MODEL; ER STRESS;
D O I
10.1038/s41419-022-04963-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Phosphatidylinositol 3 kinase (PI3K)/AKT (also called protein kinase B, PKB) signalling regulates various cellular processes, such as apoptosis, cell proliferation, the cell cycle, protein synthesis, glucose metabolism, and telomere activity. Corneal epithelial cells (CECs) are the outermost cells of the cornea; they maintain good optical performance and act as a physical and immune barrier. Various growth factors, including epidermal growth factor receptor (EGFR) ligands, insulin-like growth factor 1 (IGF1), neurokinin 1 (NK-1), and insulin activate the PI3K/AKT signalling pathway by binding their receptors and promote antiapoptotic, anti-inflammatory, proliferative, and migratory functions and wound healing in the corneal epithelium (CE). Reactive oxygen species (ROS) regulate apoptosis and inflammation in CECs in a concentration-dependent manner. Extreme environments induce excess ROS accumulation, inhibit PI3K/AKT, and cause apoptosis and inflammation in CECs. However, at low or moderate levels, ROS activate PI3K/AKT signalling, inhibiting apoptosis and stimulating proliferation of healthy CECs. Diabetes-associated hyperglycaemia directly inhibit PI3K/AKT signalling by increasing ROS and endoplasmic reticulum (ER) stress levels or suppressing the expression of growth factors receptors and cause diabetic keratopathy (DK) in CECs. Similarly, hyperosmolarity and ROS accumulation suppress PI3K/AKT signalling in dry eye disease (DED). However, significant overactivation of the PI3K/AKT signalling pathway, which mediates inflammation in CECs, is observed in both infectious and noninfectious keratitis. Overall, upon activation by growth factors and NK-1, PI3K/AKT signalling promotes the proliferation, migration, and anti-apoptosis of CECs, and these processes can be regulated by ROS in a concentration-dependent manner. Moreover, PI3K/AKT signalling pathway is inhibited in CECs from individuals with DK and DED, but is overactivated by keratitis.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Cardamonin inhibits the progression of oesophageal cancer by inhibiting the PI3K/AKT signalling pathway
    Wang, Zijie
    Liu, Hui
    Hu, Qing
    Shi, Lei
    Lu, Muhan
    Deng, Mingming
    Luo, Gang
    JOURNAL OF CANCER, 2021, 12 (12): : 3597 - 3610
  • [42] Germacrone improves liver fibrosis by regulating the PI3K/AKT/mTOR signalling pathway
    Ji, De
    Zhao, Qi
    Qin, Yuwen
    Tong, Huangjin
    Wang, Qiaohan
    Yu, Mengting
    Mao, Chunqin
    Lu, Tulin
    Qiu, Jinchun
    Jiang, Chengxi
    CELL BIOLOGY INTERNATIONAL, 2021, 45 (09) : 1866 - 1875
  • [43] PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches
    Caforio, Matteo
    de Billy, Emmanuel
    De Angelis, Biagio
    Iacovelli, Stefano
    Quintarelli, Concetta
    Paganelli, Valeria
    Folgiero, Valentina
    CANCERS, 2021, 13 (16)
  • [44] ANALYSIS OF PI3K/AKT/mTOR SIGNALLING PATHWAY IN HIGH RISK NEUROBLASTIC TUMOURS
    Izycka-Swieszewska, Ewa
    Drozynska, Elzbieta
    Rzepko, Robert
    Kobierska-Gulida, Grazyna
    Grajkowska, Wieslawa
    Perek, Danuta
    Balcerska, Anna
    POLISH JOURNAL OF PATHOLOGY, 2010, 61 (04) : 192 - 198
  • [45] Cyclophilin A as a downstream effector of PI3K/Akt signalling pathway in multiple myeloma cells
    Lin, Zuo-Lin
    Wu, Hsin-Jou
    Chen, Jin-An
    Lin, Kuo-Chih
    Hsu, Jung-Hsin
    CELL BIOCHEMISTRY AND FUNCTION, 2015, 33 (08) : 566 - 574
  • [46] Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway
    Bortul, R
    Tazzari, PL
    Billi, AM
    Tabellini, G
    Mantovani, I
    Cappellini, A
    Grafone, T
    Martinelli, G
    Conte, R
    Martelli, AM
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) : 677 - 686
  • [47] Modulating the PI3K Signalling Pathway in Activated PI3K Delta Syndrome: a Clinical Perspective
    Lucinda J. Berglund
    Journal of Clinical Immunology, 2024, 44
  • [48] Modulating the PI3K Signalling Pathway in Activated PI3K Delta Syndrome: a Clinical Perspective
    Berglund, Lucinda J.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (01)
  • [49] PI3K integrates cAMP and Akt signalling of the μ-opioid receptor
    Madishetti, Sreedhar
    Schneble, Nadine
    Koenig, Christian
    Hirsch, Emilio
    Schulz, Stefan
    Mueller, Joerg P.
    Wetzker, Reinhard
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (13) : 3328 - 3337
  • [50] The role of the PI3K/AKT signalling pathway in bFGF/PDGF composite hydrogel promoting the repair of spinal cord injuries
    Cai, Junying
    Qi, Zhimin
    Tang, Wei
    Hu, Yanhui
    Sheng, Hongguang
    ANNALI ITALIANI DI CHIRURGIA, 2021, 92 (01) : 92 - 97